HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Safar Farajnia Selected Research
Safar Farajnia Research Topics
Disease
43
Neoplasms (Cancer)
11/2023 - 01/2009
8
Infections
01/2024 - 01/2013
6
Carcinoma (Carcinomatosis)
08/2022 - 05/2012
6
Non-alcoholic Fatty Liver Disease
12/2021 - 01/2016
5
Lung Neoplasms (Lung Cancer)
01/2019 - 01/2018
4
Neoplasm Metastasis (Metastasis)
01/2021 - 05/2012
3
Breast Neoplasms (Breast Cancer)
11/2023 - 03/2015
3
Colonic Neoplasms (Colon Cancer)
08/2022 - 01/2012
3
Pseudomonas Infections
03/2021 - 01/2013
3
Sarcoma (Soft Tissue Sarcoma)
01/2019 - 01/2013
3
Adenocarcinoma of Lung
01/2019 - 01/2019
3
Infarction (Infarctions)
01/2017 - 06/2012
3
Catalepsy
12/2013 - 01/2012
2
Cross Infection (Nosocomial Infection)
09/2023 - 10/2014
2
COVID-19
01/2023 - 01/2023
2
Pathologic Neovascularization
01/2023 - 01/2021
2
Burns
02/2021 - 01/2021
2
Inflammation (Inflammations)
04/2020 - 09/2016
2
Carcinogenesis
12/2018 - 01/2018
2
B-Cell Lymphoma (Lymphoma, B Cell)
07/2018 - 01/2016
2
Hepatocellular Carcinoma (Hepatoma)
03/2018 - 12/2017
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017 - 09/2013
2
Glioblastoma (Glioblastoma Multiforme)
12/2016 - 12/2016
2
Head and Neck Neoplasms (Head and Neck Cancer)
11/2016 - 09/2014
2
Squamous Cell Carcinoma of Head and Neck
09/2014 - 05/2012
2
Ischemia
01/2014 - 06/2012
2
Phenylketonurias (Phenylketonuria)
01/2014 - 12/2013
2
Parkinson Disease (Parkinson's Disease)
12/2013 - 01/2012
1
Hypoxia (Hypoxemia)
11/2023
1
Post-Acute COVID-19 Syndrome
01/2023
1
Aberrant Crypt Foci
08/2022
1
Vitreous Detachment (Posterior Vitreous Detachment)
11/2021
1
Type 2 Diabetes Mellitus (MODY)
05/2021
1
Alcoholic Fatty Liver
04/2020
Drug/Important Bio-Agent (IBA)
12
ErbB Receptors (EGF Receptor)
IBA
06/2019 - 01/2012
9
Antibodies
IBA
10/2019 - 10/2014
8
Monoclonal Antibodies
IBA
04/2020 - 01/2009
8
Proteins (Proteins, Gene)
FDA Link
03/2020 - 01/2013
5
Antigens
IBA
01/2018 - 01/2013
4
Anti-Bacterial Agents (Antibiotics)
IBA
01/2024 - 10/2014
4
Exotoxins
IBA
01/2023 - 01/2013
4
Triglycerides (Triacylglycerol)
IBA
12/2021 - 01/2016
4
Immunotoxins (Immunotoxin)
IBA
01/2021 - 01/2017
4
epidermal growth factor receptor VIII
IBA
12/2016 - 02/2014
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2023 - 01/2021
3
Vaccines
IBA
01/2023 - 01/2013
3
Uncoupling Protein 2
IBA
05/2021 - 01/2016
3
Small Interfering RNA (siRNA)
IBA
01/2019 - 01/2018
3
Enzymes
IBA
01/2017 - 01/2011
3
Oxidopamine (6 Hydroxydopamine)
IBA
12/2013 - 01/2012
2
Peptides (Polypeptides)
IBA
01/2023 - 11/2021
2
Carbapenems (Carbapenem Antibiotics)
IBA
02/2021 - 01/2021
2
AZD 8931
IBA
01/2019 - 01/2019
2
Mitogen-Activated Protein Kinases
IBA
01/2019 - 12/2017
2
Rituximab (Mabthera)
FDA Link
07/2018 - 10/2014
2
Oligonucleotides
IBA
01/2018 - 09/2014
2
Immunosorbents
IBA
01/2017 - 06/2016
2
Biomarkers (Surrogate Marker)
IBA
11/2016 - 09/2016
2
Immunoglobulin Fragments
IBA
04/2016 - 10/2014
2
Flagellin
IBA
01/2015 - 01/2013
2
Toll-Like Receptors (Toll-Like Receptor)
IBA
09/2014 - 12/2012
2
triphenyltetrazolium
IBA
01/2014 - 06/2012
2
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2014 - 06/2012
2
Phenylalanine Ammonia-Lyase
IBA
01/2014 - 12/2013
2
5-HT1A Serotonin Receptor
IBA
12/2013 - 01/2012
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
09/2013 - 01/2013
1
Ascorbic Acid (Vitamin C)
FDA Link
Generic
11/2023
1
Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)
FDA Link
Generic
09/2023
1
Melitten (Melittin)
IBA
01/2023
1
Amino Acids
FDA Link
01/2023
1
Interferons
IBA
01/2023
1
1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)
IBA
08/2022
1
Dimethylhydrazines
IBA
08/2022
1
Dimenhydrinate (DMH)
FDA Link
Generic
08/2022
1
Cholesterol
IBA
12/2021
1
Angiogenic Proteins
IBA
11/2021
1
microplasmin
IBA
11/2021
1
Phytochemicals
IBA
06/2021
1
Fumigant 93 (D-D)
IBA
05/2021
1
3' Untranslated Regions (3' UTR)
IBA
05/2021
1
Neutralizing Antibodies
IBA
03/2021
1
Virulence Factors (Pathogenicity Factors)
IBA
03/2021
1
Imipenem
FDA Link
01/2021
1
Oxygen (Dioxygen)
IBA
01/2021
1
Gentamicins (Gentamicin)
FDA Link
Generic
01/2021
1
Fosfomycin
FDA Link
01/2021
1
Colistin (Coly-Mycin)
FDA Link
01/2021
1
Prebiotics
IBA
04/2020
1
Lipids
IBA
04/2020
1
CRISPR-Associated Proteins
IBA
03/2020
1
glucokinase regulatory protein
IBA
01/2020
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2020
1
DNA (Deoxyribonucleic Acid)
IBA
01/2020
Therapy/Procedure
26
Therapeutics
11/2023 - 03/2009
4
Drug Therapy (Chemotherapy)
06/2021 - 05/2012
2
Caloric Restriction
06/2017 - 09/2016
2
Injections
01/2017 - 01/2013
2
Enzyme Replacement Therapy
01/2014 - 12/2013
2
Ischemic Postconditioning
01/2014 - 06/2012
1
Fecal Microbiota Transplantation
04/2020